Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasee S Moorthy

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Vaccine|February 12, 2013
A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virusCindy Tamminga, Michael Kavanaugh, Charlotte Fedders, et al.
Emerging Infectious Diseases|July 21, 2016
Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015Jean-Louis Excler, Christopher J Delvecchio, Ryan E Wiley, et al.
The Lancet. Infectious Diseases|June 1, 2015
Design, recruitment, and microbiological considerations in human challenge studiesThomas C Darton, Christoph J Blohmke, Vasee S Moorthy, et al.
Plos Medicine|November 5, 2004
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adultsVasee S Moorthy, Egeruan B Imoukhuede, Paul Milligan, et al.
Vaccine|December 27, 2016
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016Miwako Kobayashi, Stephanie J Schrag, Mark R Alderson, et al.
Vaccine|September 10, 2005
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.
The Journal of Infectious Diseases|October 11, 2003
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adultsVasee S Moorthy, Margaret Pinder, William H H Reece, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malariaSheila M Keating, Philip Bejon, Tamara Berthoud, et al.
Vaccine|April 24, 2016
The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next stepsSami L Gottlieb, Carolyn D Deal, Birgitte Giersing, et al.
Vaccine|June 5, 2012
A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccinesMatthew B Laurens, Christopher J Duncan, Judith E Epstein, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Vaccine|February 12, 2013
A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virusCindy Tamminga, Michael Kavanaugh, Charlotte Fedders, et al.
Emerging Infectious Diseases|July 21, 2016
Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015Jean-Louis Excler, Christopher J Delvecchio, Ryan E Wiley, et al.
The Lancet. Infectious Diseases|June 1, 2015
Design, recruitment, and microbiological considerations in human challenge studiesThomas C Darton, Christoph J Blohmke, Vasee S Moorthy, et al.
Plos Medicine|November 5, 2004
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adultsVasee S Moorthy, Egeruan B Imoukhuede, Paul Milligan, et al.
Vaccine|December 27, 2016
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016Miwako Kobayashi, Stephanie J Schrag, Mark R Alderson, et al.
Vaccine|September 10, 2005
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.
The Journal of Infectious Diseases|October 11, 2003
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adultsVasee S Moorthy, Margaret Pinder, William H H Reece, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malariaSheila M Keating, Philip Bejon, Tamara Berthoud, et al.
Vaccine|April 24, 2016
The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next stepsSami L Gottlieb, Carolyn D Deal, Birgitte Giersing, et al.
Vaccine|June 5, 2012
A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccinesMatthew B Laurens, Christopher J Duncan, Judith E Epstein, et al.
Pageof 5